- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07609797
THE EFFECTS OF SODIUM FLUORIDE AND CHLORHEXIDINE USE ON SALIVARY IL-6 AND MATRIX METALLOPROTEINASE LEVELS IN CHILDREN WITH ACTIVE CARIES (Dental caries)
Studieoversigt
Status
Betingelser
Detaljeret beskrivelse
Biomarkers to Be Measured in the Study and Expected Benefits:Biomarkers to Be Measured in the Study and Expected Benefits:
Dental caries is a multifactorial infectious disease with high prevalence that affects a large proportion of the world's population. The fundamental pathogenesis of the disease is characterized by tissue destruction caused by complex and synergistic biological processes that arise from the interaction of acids-produced through the fermentation of dietary carbohydrates by bacteria-with susceptible host factors such as dental hard tissues and saliva. The body develops an inflammatory response against dental caries, which is characterized by infection and tissue destruction; the purpose of this response is to eliminate the agent that initiated the inflammation and to restore tissue homeostasis.
As a result of bacterial stimulation and recognition, odontoblasts, pulp tissue fibroblasts, and immune cells such as dendritic cells, macrophages, and neutrophils collectively produce a large number of molecules; these include cytokines and chemokines such as interleukin-1 beta (IL-1β), tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6), interleukin-8 (IL-8), and prostaglandins, which prolong the inflammatory state and thereby support the activation of innate and adaptive immune responses.
IL-6, produced by odontoblasts and immune cells, increases markedly in the inflamed pulp. IL-6 neutralizes bacterial cell wall components by enhancing the secretion of LBP (lipopolysaccharide-binding protein) and regulates the immune response by reducing pro-inflammatory cytokine production. It also contributes to edema formation by increasing vascular permeability. It has been reported that salivary IL-6 may serve as a potential biomarker for assessing caries severity.
As caries lesions progress toward the pulp, demineralization and collagen degradation in the dentin matrix accelerate. The decrease in pH exposes collagen fibers to proteolytic enzymes, facilitating the demineralization of the dentin matrix. This acidic environment also accelerates caries progression by increasing the activation of MMPs (zinc- and calcium-dependent endopeptidases). MMPs are classified into five subgroups based on their substrate specificity and structural similarities: collagenases, stromelysins, gelatinases, matrilysins, and membrane-type MMPs. These enzymes can be activated in an acidic environment or by lactate released by cariogenic bacteria. MMP-8 (neutrophil collagenase) can cleave triple-helical fibrillar collagens into characteristic 3/4 and 1/4 fragments. MMP-9 is a gelatinase capable of degrading type IV collagen. The activation of MMP-8 and MMP-9 plays a critical role in collagen degradation in dentin caries lesions.
The activity of MMPs, which play a central role in dentin collagen degradation, also stands out as an important target for maintaining tissue balance. The control of these enzymes is primarily achieved through tissue inhibitors of metalloproteinases (TIMPs). TIMP-1 and TIMP-2 are the primary regulators of MMP activity and effectively prevent excessive extracellular matrix (ECM) degradation . TIMP-2 exhibits strong inhibition of polymorphonuclear cell (PMN)-derived MMPs, while TIMP-1 demonstrates more pronounced inhibition of fibroblast-derived MMPs.
Inhibition of MMP activity is considered a potential strategy for slowing caries progression and preventing dentin erosion. In this context, sodium fluoride (NaF) and chlorhexidine (CHX) are cited in the literature as the principal agents capable of reducing MMP activity. NaF has been shown to inhibit the catalytic activity of recombinant MMP-8 and MMP-9. Similarly, CHX can largely prevent collagen degradation in demineralized dentin and can demonstrate long-lasting anti-MMP effects by binding electrostatically to the dentin matrix.
All of these findings demonstrate that inflammation can be objectively measured through both local and systemic biomarkers. The dynamic interaction between pro-inflammatory signals and matrix degradation, along with the endogenous inhibitors involved in this process, is of critical importance for the preservation of dentin tissue and the control of caries progression. However, studies that comprehensively reveal the molecular-level interactions of this axis, particularly in caries-active children, are limited in the literature. In this context, the aim of our study is to compare the biomarkers IL-6, MMP-8, MMP-9, and TIMP-1-representing the key components of the inflammation-matrix degradation axis-between healthy children and caries-active children, and to evaluate the effects of materials such as NaF and CHX used in caries prevention on these parameters.
Biomarker Analysis The levels of IL-6, MMP-8, MMP-9, and TIMP-1 in saliva samples will be evaluated using human saliva enzyme-linked immunosorbent assay (ELISA) kits. Biomarker analyses (ELISA) of the samples will be performed at the ALKU Faculty of Medicine Pharmacology Laboratory.
The obtained data will be statistically analyzed. Descriptive statistics: Quantitative variables will be expressed as mean ± standard deviation or median and interquartile range (IQR), and qualitative variables will be expressed as frequencies and percentages.
Between-group comparisons and within-group changes over time will be evaluated using appropriate parametric or non-parametric tests.
Results will be interpreted by correlating changes in salivary biomarker levels with clinical findings.
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: GÜL KESKİN, DDS, PhD
- Telefonnummer: 905444468857
- E-mail: gul.keskin@alanya.edu.tr
Undersøgelse Kontakt Backup
- Navn: BİNNUR B ÖZDEMİR, DDS
- Telefonnummer: 905069033834
- E-mail: busra.ozdemir@alanya.edu.tr
Studiesteder
-
-
Antalya
-
Alanya, Antalya, Tyrkiet (Türkiye), 07450
- Rekruttering
- Alanya Alaaddin Keykubat University, Faculty of Dentistry
-
Kontakt:
- GÜL KESKİN, DDS, PhD
- Telefonnummer: 905444468857
- E-mail: gul.keskin@alanya.edu.tr
-
Kontakt:
- BİNNUR B ÖZDEMİR, DDS
- Telefonnummer: 905069033834
- E-mail: busra.ozdemir@alanya.edu.tr
-
Ledende efterforsker:
- GÜL KESKİN, DDS, PhD
-
Underforsker:
- BİNNUR B ÖZDEMİR, DDS
-
Underforsker:
- ERKAN MAYTALMAN, DDS, PhD
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Barn
Tager imod sunde frivillige
Beskrivelse
Inclusion Criteria:
- For active caries groups (Groups A, B, C):
Participants must meet at least one of the following criteria:
dmft ≥ 6, or Presence of at least one active caries lesion with an ICDAS code ≥ 3, or Clinical evidence of active caries on ≥ 10 surfaces
For the dmft = 0 reference group (Group D):
All surfaces caries-free and non-high-risk individuals (ICDAS II = 0). Only baseline (T0) saliva sampling will be performed.
Exclusion Criteria:
- Professional topical fluoride application or continuous CHX use within the past 3 months Systemic chronic disease, immunodeficiency, or severe neuromotor disorder Presence of gingival redness, swelling, or bleeding All first permanent molars not yet erupted Known allergy to fluoride compounds Behavioral problems that would prevent safe cooperation during application Regular antibiotic use within the past 1 month According to Ethics Committee regulations: individuals with infectious diseases, those at high risk of endocarditis, those with allergy to varnish components, individuals with a history of substance dependence, those with epilepsy, and those with renal failure or immunosuppression
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Grundvidenskab
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: 5% Sodium Fluoride (NaF) Varnish
Caries-active children aged 6-8 years.
Teeth are gently air-dried for 30 seconds under isolation with cotton rolls and aspirator.
Approximately 0.5 mL of 5% NaF varnish is applied to all teeth sequentially by quadrant starting from the upper jaw using an applicator tip and left in place for 1 minute.
Parents are instructed to restrict water and hard food intake for 1 hour post-application.
Saliva samples collected at T0, T1 and T2.
n=20.
|
Teeth are gently air-dried for 30 seconds under isolation with cotton rolls and aspirator.
Approximately 0.5 mL of 5% NaF varnish is applied to all tooth surfaces sequentially by quadrant starting from the upper jaw using an applicator tip and left in place for 1 minute.
Parents are instructed to restrict water and hard food intake for 1 hour post-application.
This is a routine preventive application; no off-label use is involved.
|
|
Eksperimentel: 2% Chlorhexidine Pre-Treatment + 5% NaF Varnish
Caries-active children aged 6-8 years.
Teeth are gently air-dried for 30 seconds under isolation.
2% CHX is applied to the lesion/tooth surfaces using an applicator tip and left for 30 seconds.
Excess CHX is absorbed, an additional 30 seconds was allowed to pass.NaF varnish was then applied and left for 1 minute.
Precautions are taken to prevent CHX ingestion.
Parents are instructed to restrict water and hard food intake for 1 hour post-application.
Saliva samples collected at T0, T1 and T2.
n=20.
|
Following isolation and air-drying, 2% chlorhexidine solution is applied to the lesion/tooth surfaces using an applicator tip and left in place for 30 seconds.
Excess CHX is then absorbed.
Precautions are taken to prevent ingestion.
This pre-treatment is performed immediately prior to 5% NaF varnish application.
This is a routine preventive application; no off-label use is involved.
|
|
Aktiv komparator: Standard Care / Oral Hygiene Education
Caries-active children aged 6-8 years.
No professional topical agent is applied.
Children and parents receive standardized oral hygiene education including twice-daily brushing with fluoride toothpaste, reduction of sugar frequency, and a brief parent information brochure.
Necessary treatment will be offered at the end of the study upon request (wait-list design).
Saliva samples collected at T0 and T2.
n=20.
|
Children and parents receive standardized oral hygiene education including instruction on twice-daily brushing with fluoride toothpaste, reduction of sugar intake frequency, and a brief parent information brochure.
No professional topical agent is applied.
Necessary treatment will be offered at the end of the study upon request (wait-list design).
|
|
Ingen indgriben: Caries-Free Healthy Control
Age- and sex-matched caries-free children (ICDAS II = 0, dmft = 0) aged 6-8 years.
No intervention is applied.
Clinical assessment (dmft/ICDAS) is performed and recorded.
Saliva sampling is performed at T0 only.
This group serves as a non-randomized biological reference group.
n=20.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Salivary MMP-8 Levels
Tidsramme: Baseline (T0), post-application (T1) , 1 month post-intervention (T2)
|
Change in salivary matrix metalloproteinase-8 (MMP-8) concentration measured by ELISA from baseline (T0) to post-application (T1) and 1 month post-intervention (T2) , and comparison between caries-active and caries-free groups at baseline.
Unstimulated whole saliva samples will be analyzed using CE-marked/FDA-approved human saliva ELISA kits.
Results expressed as ng/mL.
|
Baseline (T0), post-application (T1) , 1 month post-intervention (T2)
|
|
Change in Salivary IL-6 Levels
Tidsramme: Baseline (T0), post-application (T1), 1 month post-intervention (T2)
|
Change in salivary interleukin-6 (IL-6) concentration measured by ELISA from baseline (T0) to post-application (T1) and 1 month post-intervention (T2) , and comparison between caries-active and caries-free groups at baseline.
Unstimulated whole saliva samples will be collected, centrifuged at 5,000 g for 10 minutes at 4°C, stored at -80°C, and analyzed using CE-marked/FDA-approved human saliva ELISA kits.
Results expressed as pg/mL.
|
Baseline (T0), post-application (T1), 1 month post-intervention (T2)
|
|
Change in Salivary MMP-9 Levels
Tidsramme: Baseline (T0), post-application (T1), 1 month post-intervention (T2)
|
Change in salivary matrix metalloproteinase-9 (MMP-9) concentration measured by ELISA from baseline (T0) to post-application (T1) and 1 month post-intervention (T2), and comparison between caries-active and caries-free groups at baseline.
Unstimulated whole saliva samples will be analyzed using CE-marked/FDA-approved human saliva ELISA kits.
Results expressed as ng/mL.
|
Baseline (T0), post-application (T1), 1 month post-intervention (T2)
|
|
Change in Salivary TIMP-1 Levels
Tidsramme: Baseline (T0), post-application (T1), 1 month post-intervention (T2)
|
Change in salivary tissue inhibitor of metalloproteinase-1 (TIMP-1) concentration measured by ELISA from baseline (T0) to post-application (T1) and 1 month post-intervention (T2), and comparison between caries-active and caries-free groups at baseline.
Unstimulated whole saliva samples will be analyzed using CE-marked/FDA-approved human saliva ELISA kits.
Results expressed as ng/mL.
|
Baseline (T0), post-application (T1), 1 month post-intervention (T2)
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Studieleder: GÜL KESKİN, DDS, PhD, Alanya Alaaddin Keykubat University
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 2025-KAEK-44
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Caries hos børn
-
University of LiegeDMG Paris DescartesUkendtZirconia Monolithic Dental Restorations: In-mouth Behaviour, LTD og WearBelgien
Kliniske forsøg med 5% Sodium Fluoride Varnish
-
GlaxoSmithKlineTrukket tilbage
-
Sarah Sabry HashemAfsluttet
-
Eli Lilly and CompanyAfsluttet
-
University of MalayaRekrutteringOrtodontisk apparatkomplikationMalaysia
-
Dr. Soetomo General HospitalAfsluttetErektil dysfunktionIndonesien
-
Cairo UniversityRekrutteringMaternelle komplikationer efter oral antikoagulering ved påbegyndelse tidligt og sent efter kejsersnit udført for patienter med mekanisk hjerteklapproteseEgypten
-
Cairo UniversityIkke rekrutterer endnuMolar Incisor Hypomineralisation
-
GlaxoSmithKlineAfsluttetMundhygiejne | Ydre tandfarveCanada
-
Beaty DentAfsluttetCaries i tænderneAlbanien
-
Eli Lilly and CompanyAfsluttetBenign prostatahyperplasiTaiwan, Japan